| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| R&D Expense | $103.7M | +30.7% |
| SG&A Expense | $26.0M | -9.9% |
| Operating Income | -$129.7M | -19.9% |
| Income Tax | $0 | — |
| Net Income | -$123.5M | -15.9% |
| EPS (Basic) | -$2.58 | +5.8% |
| EPS (Diluted) | -$2.58 | +5.8% |
| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $111.5M | -48.3% |
| Current Assets | $116.4M | -47.2% |
| Total Assets | $119.7M | -47.0% |
| Current Liabilities | $28.3M | +22.5% |
| Total Liabilities | $49.0M | +7.9% |
| Stockholders' Equity | $70.7M | -60.8% |
| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$104.0M | -15.0% |
| Investing Cash Flow | -$98K | +63.0% |
| Financing Cash Flow | $77K | -99.9% |